Advances in technology have helped harness the power of genomic sequencing, offering new hope in the fight against genetic diseases. Katie Hampson reports.
What was once a pipe dream to early genetics researchers is now a reality as the genomic age brings new ways to detect and treat disease, and offers families with devastating inherited illnesses a helping hand against fate.
We humans have never known more about our genetics than now, says Professor Nigel Laing, an internationally respected genetics expert from Perths Harry Perkins Institute of Medical Research.
It is all about giving information to people that they can use to make decisions with.
The complex science of genomics isnt exactly sexy stuff but genetics experts say the benefits to medicine, in particular, have the potential to be huge.
Already, Australian scientists have been relying heavily on genomic sequencing to trace infection outbreaks and, more recently, to understand how COVID-19 is spread in an effort to contain the virus.
Sequencing the genome of viruses allow us to quickly identify the emergence of new strains, explains Timo Lassmann, head of the genetics and rare diseases program at Telethon Kids Institute.
Other powerful information that has emerged from sequencing concerns recessive genes for certain diseases.
Most of us are carriers of mutations that are harmless. But Professor Laing says that this can change if we start a family with a partner who has a mutation in the same gene.
Now, couples can undergo genomic sequencing, which he says will identify if they have recessive genes for certain diseases, as well as their risk of having a child affected by a genetic disease. This means couples no longer have to find out they are at risk of having a child with a recessive disease by having an affected child they will be informed beforehand, he explains.
All this is possible because scientists are given a comprehensive picture of a persons genetic information when they sequence their genes.
Professor Laing says exciting discoveries about which genes are responsible for certain life-limiting rare or undiagnosed disorders are occurring more and more, thanks to the sophistication of todays sequencing technology.
Research suggests rare conditions affect one in 50 Australians, he says.
The genome contains the complete set of instructions to build a human being, Professor Lassmann says. Understanding what is written in the genome, and how the information is read and used, is highly relevant to understanding human disease and health.
When many people talk about their DNA, what they are really referring to is their genome.
Each of us has a genome made up of more than 3 billion letters of DNA, found in nearly every cell in the body, and errors can trigger a vast array of disorders.
The first whole human genome to be sequenced began in 1990 and took 13 years.
It was not without controversy and not every promise has materialised but it produced some great strides in medicine.
And, thanks to technological advances, it can now be done in a day for a fraction of the cost, leading to an explosion in genetic research.
Professor Laing says genomic sequencing has already offered tremendous benefits to many people.
For example, scientists have used sequencing to hunt for genes linked to different types of disease, such as breast cancer, and to learn more about inherited disorders, including Huntingtons disease and cystic fibrosis. Families can then find out if they might pass the conditions on to the next generation.
Professor Laing, who has been involved in the discovery of more than 30 disease genes, says that when a diagnosis can be made immediately, it transforms the lives of families.
Take Duchenne muscular dystrophy. This life-limiting condition, which mainly affects young boys, causes every muscle in the body, including the heart, to deteriorate.
One of the problems with DMD is that the early signs are often vague and confusing, which means children are put through a battery of tests in the first years of their life as doctors try their best to work out the cause. These tests can be uncomfortable, invasive, costly and will not necessarily be effective.
Now, thanks to genomic sequencing, Professor Laing says this condition can be pinpointed quickly and some boys with it can now be treated immediately.
The great thing about genetic testing is that now, for a large number of diseases, the first test a clinician will order is a genetic test and that can get the answer and save a whole lot of other different tests, he explains.
Furthermore, when we do a genetic test, we find the variant and that can lead to switching which medication the patient is on from something that isnt going to work to something that is going to work and that is just joyful.
Australia has had a long history of excellence in genetics research and our scientists continue to help discover new disease genes and world-first treatments.
A team of scientists, led by Perth professors Steve Wilton and Sue Fletcher, discovered the first treatment in the world to drastically improve the health of many young people with DMD.
Whats more, Dr David Chandlers Perth research was crucial in helping to discover a new disease gene responsible for a condition that causes facial deformity. The condition can be devastating, with some babies needing breathing support and a tracheostomy, and the deformity often continues to worsen as the child grows.
One WA family has 12 members who are affected. However, a breakthrough like this meant they finally had the answers they longed for, and so did other families living with the same condition in other parts of the world, including in the US. For the first time, those families are also able to find out if they will pass the condition on to the next generation and now have reproductive choices.
Professor Laing, who jointly supervised Dr Chandlers research, says hunting for disease genes is like putting together an international jigsaw puzzle.
For a start, DNA from families across the globe needs to be cross-referenced.
And, back when Dr Chandler started hunting for this disease gene some 20 years ago, he could only take his research so far because the technology at the time was limited.
The latest genetic sequencing technology provides scientists with a goldmine of information, which can help researchers achieve the kind of eureka moment experienced by Dr Chandler and the US team of scientists he collaborated with.
In some ways, I keep feeling it is the people who have invented the new technologies that deserve all the credit here, Professor Laing says. Because before the next-generation sequencing came on board, it was just not financially possible to do all the good as a researcher that you would like to do.
He says as sequencing has become easier and cheaper to do, more diseases have opened up.
Professor Lassmann agrees the field of genomics is full of promise, adding: I can see the potential across many diseases and (more) people will benefit from genetic screening when treatments and strategies for disease management become available for the majority of possible diseases.
Genome sequencing is used in many contexts, says Telethon Kids Institute Professor Timo Lassmann, including for finding the cause for rare and undiagnosed diseases and in cancer. Broadly speaking, however, genome sequencing can currently be used for:
Screening: Detecting conditions and risk factors early before disease occurs, allowing for early intervention and changes in lifestyle decisions.
Diagnosis: Identifying the exact cause of a disease.
Treatment: Identifying the most effective treatment option, thus minimising adverse side-effects while improving patient outcomes.
Cracking the code - The West Australian
- Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in Kids - HealthDay - November 21st, 2021
- Immunosuppressants linked to severe reactions in people with common genetic profile - Stanford Medical Center Report - November 21st, 2021
- A video that originated on InfoWars is filled with falsehoods about COVID-19 vaccines - PolitiFact - November 21st, 2021
- Gene signature may give an upper hand in metastatic breast cancer - Baylor College of Medicine News - November 21st, 2021
- Lung cancer management in the era of precision medicine - Express Healthcare - November 21st, 2021
- Powerful gene-based testing by integrating long-range chromatin interactions and knockoff genotypes - pnas.org - November 21st, 2021
- Stoke Therapeutics Announces Presentations from the Company's Dravet Syndrome Program at the American Epilepsy Society 2021 Annual Meeting - Business... - November 21st, 2021
- European Commission approves Roche's Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer |... - November 21st, 2021
- Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring - pnas.org - November 21st, 2021
- Vertex Announces Reimbursement Agreement in Spain for KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat People With... - November 21st, 2021
- Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled... - November 21st, 2021
- Gene Therapy and Genetic Engineering - MU School of Medicine - November 17th, 2021
- Gene editing: Great for medicine but ethical issues arise - November 17th, 2021
- Gene on, gene off: Chroma Medicine turns lights on with $125M to control gene expression with ex-Editas, Regeneron leaders - FierceBiotech - November 17th, 2021
- gene therapy | Description, Uses, Examples, & Safety ... - November 17th, 2021
- Sarepta Therapeutics Names Louise Rodino-Klapac, Ph.D., Head of Research and Development - Yahoo Finance - November 17th, 2021
- CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes -... - November 17th, 2021
- 8 medical advances you may have missed during COVID-19 - AAMC - November 17th, 2021
- PNAS Papers on Woodrat Microbiome, Maternal Cannabis Use, Gene-Based Testing - GenomeWeb - November 17th, 2021
- Single Cell Multiomic Atlas of the Human Retina: An Integrative Analysis - Genetic Engineering & Biotechnology News - November 17th, 2021
- Map of Mouse Iris Offers New Look at the Eye - Howard Hughes Medical Institute - November 17th, 2021
- Is every gene associated with cancer? - Medical News Today - November 15th, 2021
- Years later, a first-of-its-kind treatment shows the power, and limits, of gene therapy - BioPharma Dive - November 15th, 2021
- A mammoth solution - Harvard Office of Technology Development - November 15th, 2021
- Coave Therapeutics Strengthens Leadership Team with the Appointments of Thomas Blaettler MD as Chief Medical Officer and Patricia Franon PhD as Chief... - November 15th, 2021
- Cell and Gene Therapy Catapult and Deep Science Ventures collaborate to overcome barriers in ATMPs - BioPharma-Reporter.com - November 15th, 2021
- Regenerative Medicine Market to reach US$ 25,959.5 Mn by end of 2028, Says Coherent Market Insights - PRNewswire - November 15th, 2021
- Dr Pengyi Yang wins National Stem Cell Foundation Metcalf Prize - News - The University of Sydney - November 15th, 2021
- Researchers make strides identifying genetic causes of rare neurodevelopmental disorders in the Turkish and worldwide populations - Baylor College of... - November 15th, 2021
- Saving the world with synthetic biology - Scope - Scope - November 15th, 2021
- GenSight Biologics to Present New Clinical Data of LUMEVOQ and GS030 Gene Therapies at the American Academy of Ophthalmology 2021 Meeting - Business... - November 15th, 2021
- Gene Therapy ADVM-022 Provides Mixed Efficacy, Safety in Treating DME - MD Magazine - November 15th, 2021
- Role of gene associated with Alzheimer's disease in brain's immune cells investigated by scientists - Devdiscourse - November 15th, 2021
- Attitudes among parents of persons with autism spectrum disorder towards information about genetic risk and future health | European Journal of Human... - November 15th, 2021
- Pierre Fabre and the EspeRare Foundation start the EDELIFE clinical trial of a prenatal treatment for a rare genetic disease, XLHED - PRNewswire - November 15th, 2021
- Arizona researchers have a Valley fever vaccine for dogs and that's good news for humans - KJZZ - November 15th, 2021
- Study revealed the function of mysterious structure found on neurons - Tech Explorist - November 15th, 2021
- New Research Helps Explain the Genetic Basis of Why We Look the Way We Do - UC San Diego Health - November 15th, 2021
- Gene Therapy Shows Early Promise as Angelman Syndrome Treatment | Newsroom - UNC Health and UNC School of Medicine - October 26th, 2021
- Report by Mott Center researchers named NIEHS Extramural Paper of the Month - The South End - October 26th, 2021
- Clinical Data from Editas Medicines Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene... - October 26th, 2021
- Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms - GenomeWeb - October 26th, 2021
- Alcyone Therapeutics Strengthens Executive Team with New Senior Leadership Appointments - WABI - October 26th, 2021
- The Genomic Revolution: Why Investors Are Paying Attention - Visual Capitalist - October 26th, 2021
- Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T in Advanced ROR1+ Hematological and Solid Tumors - WAGM - October 26th, 2021
- 5 Trends Shaping the Future of eCommerce - Visual Capitalist - October 26th, 2021
- Anatomy texts should show sex as a spectrum to include intersex people - The Conversation AU - October 26th, 2021
- Early Results of Gene Therapy for Angelman Syndrome Look Promising - AJMC.com Managed Markets Network - October 24th, 2021
- Ten Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune Disease - HealthDay News - October 24th, 2021
- Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit - Yahoo Finance - October 24th, 2021
- Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery... - October 24th, 2021
- ViaCyte to Present at the Jefferies Gene Therapy/Editing Summit - WCAX - October 24th, 2021
- Lovelace Biomedical Presents a New Webinar on Rare Diseases and Gene Therapy Preclinical Research - PRNewswire - October 24th, 2021
- Novartis has negotiated Zolgensma access for half of the European SMA population, exec says. How'd it get there? - FiercePharma - October 24th, 2021
- Senti Bio CEO Appointed to The Alliance for Regenerative Medicine 2022 Board of Directors - StreetInsider.com - October 24th, 2021
- ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs - MedCity News - October 24th, 2021
- From cancer to Crohn, Israel pushes precision medicine to the next level - The Jerusalem Post - October 24th, 2021
- Tulane scientists unravel 50-year-old medical mystery behind toddlers' deaths from RSV vaccine - Tulane News - October 24th, 2021
- Dr. Helen Heslop elected to the National Academy of Medicine - Baylor College of Medicine News - October 24th, 2021
- Boehringer Acquires Rights to Potential CF Inhalation Gene Therapy - Cystic Fibrosis News Today - October 24th, 2021
- LogicBio Therapeutics Announces Successful Repopulation of Diseased Livers in Mice with Healthy Corrected Hepatocytes in Two New Indications Using... - October 24th, 2021
- Global Pharmaceutical Contract Development and Manufacturing Markets, 2021-2026 - Increasing Demand for Biological & Cell and Gene Therapies /... - October 24th, 2021
- Precision medicine data dive shows water pill may be viable to test as Alzheimer's treatment - The Highland County Press - October 24th, 2021
- Hunterian Medicine Licenses Inscriptas MAD7 Nuclease to Advance Gene Editing Research and Development - Yahoo Finance - October 17th, 2021
- Precision medicine data dive shows water pill may be viable to test as Alzheimer's treatment - National Institutes of Health - October 17th, 2021
- 4 Biotechs to Watch Amid Rising Prominence of Gene Therapies - Yahoo Finance - October 17th, 2021
- The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics - Yahoo Finance - October 17th, 2021
- Could an Old Drug Be a New Alzheimers Treatment? - AARP - October 17th, 2021
- 5 Slides: Gene therapy and the promise for rare disease - State of Reform - State of Reform - October 17th, 2021
- Harvard's R&D alliance with Resilience to advance manufacture of complex medicines - Harvard Gazette - October 17th, 2021
- Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress - StreetInsider.com - October 17th, 2021
- Genetic screening test leads to discovery of a family trait - Sanford Health News - October 17th, 2021
- Filling the gaps: connecting genes to diseases through proteins - EurekAlert - October 17th, 2021
- Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development - GlobeNewswire - October 17th, 2021
- Polygenic screening of embryos is here, but is it ethical? - The Guardian - October 17th, 2021
- Wolter Earns Young Investigator Award | Newsroom - UNC Health and UNC School of Medicine - October 17th, 2021
- Patient Care on the Precipice of Transformation at Penn Medicine's New Pavilion - pennmedicine.org - October 17th, 2021
- ViaCyte to Present at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa - PRNewswire - October 11th, 2021
- CRISPR is revolutionizing medicine its origin story is pretty incredible, too - Freethink - October 11th, 2021
- Longevity Foundation to Fund Geroscience Research with 860M - Labiotech.eu - October 11th, 2021